UBS Group
APXH

UBS Group’s APEX HealthCare ETF APXH Stock Holding History

UBS Group’s Portfolio APXH Stock Details APXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-811
Closed -$7.14K – 11469
2022
Q4 		$7.14K Buy
811
+376
+86% +$3.23K ﹤0.01% 8933
2022
Q3 		$3K Buy
+435
New +$3.7K ﹤0.01% 9663

UBS Group's APXH Position: Q1 2023 in Review

UBS Group sold out of APEX HealthCare ETF (APXH) in Q1 2023, closing a stake of 811 shares — an estimated $7.14K sold.

UBS Group first reported a position in APXH in Q3 2022 and held it in 2 quarters. The position peaked at $7.14K in Q4 2022. 0 funds tracked by Wall St. Rank hold APXH as of Q1 2023.

  • UBS Group reported no remaining APEX HealthCare ETF position as of Q1 2023 after selling out during the quarter.
  • UBS Group sold 811 APEX HealthCare ETF shares in Q1 2023, an estimated $7.14K.
  • UBS Group first reported a position in APEX HealthCare ETF in Q3 2022 and held it in 2 quarters.
  • UBS Group's APEX HealthCare ETF position peaked at $7.14K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held APEX HealthCare ETF as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.